We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+4.51%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$369M
AUM Growth
-$418K
Cap. Flow
-$12.4M
Cap. Flow %
-3.37%
Top 10 Hldgs %
23.09%
Holding
244
New
26
Increased
87
Reduced
73
Closed
45

Top Buys

Rank Stock Value
1
MO icon
Altria Group
MO
+$3.02M
2
PFE icon
Pfizer
PFE
+$3M
3
CVS icon
CVS Health
CVS
+$2.72M
4
KHC icon
Kraft Heinz
KHC
+$2.68M
5
EXC icon
Exelon
EXC
+$2.67M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$3.8M
2
FUN icon
Cedar Fair
FUN
+$2.55M
3
AZN icon
AstraZeneca
AZN
+$2.41M
4
GSK icon
GSK
GSK
+$2.38M
5
PPL
PPL Corp
PPL
+$2.23M

Sector Composition

Rank Sector Weight
1 Technology 14.63%
2 Healthcare 14.59%
3 Consumer Staples 11.98%
4 Industrials 10.74%
5 Utilities 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SEE
26
DELISTED
Sealed Air
SEE
$4.08M 1.11%
91,142
+263
+0.3% +$11.6K
ST icon
27
Sensata Technologies
ST
$6.46B
$4.07M 1.1%
95,350
-2,233
-2% -$91.8K
FUL icon
28
H.B. Fuller
FUL
$3.14B
$4.01M 1.09%
78,372
-2,639
-3% -$136K
LPNT
29
DELISTED
LifePoint Health, Inc.
LPNT
$4M 1.09%
59,588
+758
+1% +$47.9K
UHS icon
30
Universal Health Services
UHS
$9.29B
$3.9M 1.06%
31,957
+1,652
+5% +$197K
PFE icon
31
Pfizer
PFE
$143B
$3.84M 1.04%
120,455
+95,028
+374% +$3M
CVS icon
32
CVS Health
CVS
$136B
$3.48M 0.94%
43,289
+34,448
+390% +$2.72M
CAMP
33
DELISTED
CalAmp Corp.
CAMP
$3.31M 0.9%
7,081
-126
-2% -$53.5K
TSCO icon
34
Tractor Supply
TSCO
$16.3B
$3.28M 0.89%
302,930
-13,965
-4% -$166K
MON
35
DELISTED
Monsanto Co
MON
$3.26M 0.88%
27,558
-32,607
-54% -$3.8M
FSS icon
36
Federal Signal
FSS
$7.29B
$3.2M 0.87%
184,556
+3,370
+2% +$52.9K
MO icon
37
Altria Group
MO
$122B
$3.07M 0.83%
+41,225
New +$3.02M
PBH icon
38
Prestige Consumer Healthcare
PBH
$2.4B
$3.07M 0.83%
58,105
-2,372
-4% -$127K
VZ icon
39
Verizon
VZ
$183B
$3.02M 0.82%
67,647
+10,437
+18% +$486K
WCC
40
WESCO International
WCC
$15.9B
$2.96M 0.8%
51,611
+691
+1% +$42.9K
CNA icon
41
CNA Financial
CNA
$13.9B
$2.85M 0.77%
58,430
+878
+2% +$40.1K
GILD icon
42
Gilead Sciences
GILD
$169B
$2.82M 0.76%
+39,790
New +$2.65M
KS
43
DELISTED
KapStone Paper and Pack Corp.
KS
$2.79M 0.76%
135,000
– –
IDTI
44
DELISTED
Integrated Device Technology I
IDTI
$2.77M 0.75%
107,408
-1,982
-2% -$48.2K
T icon
45
AT&T
T
$153B
$2.76M 0.75%
96,840
+1,365
+1% +$40.2K
CRS icon
46
Carpenter Technology
CRS
$27.5B
$2.73M 0.74%
73,027
-3,184
-4% -$118K
CSCO icon
47
Cisco
CSCO
$432B
$2.73M 0.74%
87,286
+760
+0.9% +$24.8K
TFC icon
48
Truist Financial
TFC
$66.3B
$2.71M 0.74%
+59,723
New +$2.59M
EXC icon
49
Exelon
EXC
$47.9B
$2.7M 0.73%
+105,086
New +$2.67M
PG icon
50
Procter & Gamble
PG
$353B
$2.63M 0.71%
+30,187
New +$2.66M
1
2
3 4 5

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return

Stanley-Laman Group's Q2 2017 Portfolio in Review

As of Q2 2017, Stanley-Laman Group held 244 positions worth $369M, down 0.11% from $369M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Stanley-Laman Group withdrew a net $12.4M in Q2 2017, closing 45 positions and reducing 73 holdings. Its most notable exit was Cedar Fair, an estimated $2.55M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Stanley-Laman Group opened a new position in Altria Group worth $3.07M.

  • Stanley-Laman Group's largest Q2 2017 buy was Altria Group: 41,225 shares worth $3.07M.
  • Stanley-Laman Group added most to Pfizer in Q2 2017, an estimated $3M increase.
  • Stanley-Laman Group's biggest Q2 2017 reduction was Monsanto Co, cutting an estimated $3.8M.
  • Stanley-Laman Group fully exited Cedar Fair in Q2 2017, selling an estimated $2.55M.
  • Stanley-Laman Group's ten largest holdings make up 23% of its $369M portfolio in Q2 2017.
  • Stanley-Laman Group opened 26 new positions and closed 45 in Q2 2017.
  • Stanley-Laman Group's portfolio value fell 0.11% quarter-over-quarter to $369M.

Based on Stanley-Laman Group's 13F filing for Q2 2017, filed 7 Aug 2017.